Avenue Therapeutics, Inc. (ATXI)
ATXI is quoted over the counter, not listed on an exchange. Avenue Therapeutics, Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | ATXI, quoted over the counter |
| SEC CIK | 0001644963 |
| OTC Markets tier | OTCID (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Bay Harbor Islands, FL |
| Incorporated in | DE |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These factors individually and collectively cause substantial doubt about the Company's ability to continue as a going concern to exist within one year from the date of this report." | 10-Q 2026-11-06 |
| Cash and burn | $1.5M cash; operating cash flow -$547K a quarter. | Report 2026-09-30 |
| Shares outstanding | 3,294,967 (2026-11-04); 3,183,558 a year earlier; 13,247,622 three years earlier. 3y figure adjusted for splits (1-for-75 overall). | Cover page 2026-11-04 |
| Reverse splits, 3 years | 1; latest 1-for-75 on 2024-04-26 | Source 2024-04-26 |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Delisting | 25-NSE filed | 25-NSE 2025-07-18 |
| Auditor | KPMG LLP, New York, New York, United States | PCAOB Form AP 2026-04-30 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $0 | -$691K | -$422K | $1.5M | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q2 2026 2026-06-30 | $0 | -$690K | -$475K | $1.9M | No debt tags | Needs four quarters | 10-Q 2026-08-07 |
| Q1 2026 2026-03-31 | Not filed | -$695K | -$438K | $2.4M | No debt tags | Needs four quarters | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $0 | -$709K | -$854K | $2.9M | No debt tags | $1.4M | 10-K 2026-03-30 |
| Q3 2025 2025-09-30 | $0 | -$683K | $383K | $3.7M | No debt tags | Needs four quarters | 10-Q 2026-11-06 |
| Q2 2025 2025-06-30 | $1.4M | $335K | -$176K | $3.3M | No debt tags | Needs four quarters | 10-Q 2026-08-07 |
| Q1 2025 2025-03-31 | Not filed | -$1.9M | -$1.2M | $3.5M | No debt tags | Needs four quarters | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $0 | -$1.5M | -$764K | $2.6M | No debt tags | $0 | 10-K 2026-03-30 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2025-12-15 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-11-06 |
| Latest current report | 8-K | 2026-02-23 |
| Latest proxy | DEF 14A | 2025-12-05 |
Source: SEC EDGAR submissions feed, 424 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier